亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma

细胞外小泡 肝细胞癌 医学 癌 细胞外 癌症研究 癌症 内科学 肿瘤科 病理 生物 细胞生物学
作者
Henrike Julich‐Haertel,Sabine Urban,Marcin Krawczyk,Arnulf Willms,Krzysztof Jankowski,Waldemar Patkowski,Beata Kruk,Maciej Krasnodębski,Joanna Ligocka,Robert Schwab,I. Richardsen,Sebastian Schaaf,Angelina Klein,Sebastian Gehlert,Hanna Sänger,Markus Casper,Jesús M. Bañales,Detlef Schuppan,Piotr Milkiewicz,Frank Lammert
出处
期刊:Journal of Hepatology [Elsevier BV]
卷期号:67 (2): 282-292 被引量:153
标识
DOI:10.1016/j.jhep.2017.02.024
摘要

Background & Aims Large extracellular vesicles, specifically AnnexinV+ EpCAM+ CD147+ tumour-associated microparticles (taMPs), facilitate the detection of colorectal carcinoma (CRC), non-small cell lung carcinoma (NSCLC) as well as pancreas carcinoma (PaCa). Here we assess the diagnostic value of taMPs for detection and monitoring of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Specifically, the aim of this study was to differentiate liver taMPs from other cancer taMPs, such as CRC and NSCLC. Methods Fluorescence-activated cell scanning (FACS) was applied to detect various taMP populations in patients’ sera that were associated with the presence of a tumour (AnnexinV+ EpCAM+ CD147+ taMPs) or could discriminate between cirrhosis (due to HCV or HBV) and liver cancers (AnnexinV+ EpCAM+ ASGPR1+ taMPs). In total 172 patients with liver cancer (HCC or CCA), 54 with cirrhosis and no liver neoplasia, and 202 control subjects were enrolled. Results The results indicate that AnnexinV+ EpCAM+ CD147+ taMPs were elevated in HCC and CCA. Furthermore, AnnexinV+ EpCAM+ ASGPR1+ CD133+ taMPs allowed the distinction of liver malignancies (HCC or CCA) and cirrhosis from tumour-free individuals and, more importantly, from patients carrying other non-liver cancers. In addition, AnnexinV+ EpCAM+ ASGPR1+ taMPs were increased in liver cancer-bearing patients compared to patients with cirrhosis that lacked any detectable liver malignancy. The smallest sizes of successfully detected cancers were ranging between 11–15 mm. AnnexinV+ EpCAM+ ASGPR1+ taMPs decreased at 7 days after curative R0 tumour resection suggesting close correlations with tumour presence. ROC values, sensitivity/specificity scores and positive/negative predictive values (>78%) indicated a potent diagnostic accuracy of AnnexinV+ EpCAM+ ASGPR1+ taMPs. Conclusion These data provide strong evidence that AnnexinV+ EpCAM+ ASGPR1+ taMPs are a novel biomarker of HCC and CCA liquid biopsy that permit a non-invasive assessment of the presence and possible extent of these cancers in patients with advanced liver diseases. Lay summary Microparticles (MPs) are small vesicles that bleb from the membrane of every cell, including cancer cells, and are released to circulate in the bloodstream. Since their surface composition is similar to the surface of their underlying parental cell, MPs from the bloodstream can be isolated and by screening their surface components, the presence of their parental cells can be identified. This way, it was possible to detect and discriminate between patients bearing liver cancer and chronic liver cirrhosis. Large extracellular vesicles, specifically AnnexinV+ EpCAM+ CD147+ tumour-associated microparticles (taMPs), facilitate the detection of colorectal carcinoma (CRC), non-small cell lung carcinoma (NSCLC) as well as pancreas carcinoma (PaCa). Here we assess the diagnostic value of taMPs for detection and monitoring of hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). Specifically, the aim of this study was to differentiate liver taMPs from other cancer taMPs, such as CRC and NSCLC. Fluorescence-activated cell scanning (FACS) was applied to detect various taMP populations in patients’ sera that were associated with the presence of a tumour (AnnexinV+ EpCAM+ CD147+ taMPs) or could discriminate between cirrhosis (due to HCV or HBV) and liver cancers (AnnexinV+ EpCAM+ ASGPR1+ taMPs). In total 172 patients with liver cancer (HCC or CCA), 54 with cirrhosis and no liver neoplasia, and 202 control subjects were enrolled. The results indicate that AnnexinV+ EpCAM+ CD147+ taMPs were elevated in HCC and CCA. Furthermore, AnnexinV+ EpCAM+ ASGPR1+ CD133+ taMPs allowed the distinction of liver malignancies (HCC or CCA) and cirrhosis from tumour-free individuals and, more importantly, from patients carrying other non-liver cancers. In addition, AnnexinV+ EpCAM+ ASGPR1+ taMPs were increased in liver cancer-bearing patients compared to patients with cirrhosis that lacked any detectable liver malignancy. The smallest sizes of successfully detected cancers were ranging between 11–15 mm. AnnexinV+ EpCAM+ ASGPR1+ taMPs decreased at 7 days after curative R0 tumour resection suggesting close correlations with tumour presence. ROC values, sensitivity/specificity scores and positive/negative predictive values (>78%) indicated a potent diagnostic accuracy of AnnexinV+ EpCAM+ ASGPR1+ taMPs. These data provide strong evidence that AnnexinV+ EpCAM+ ASGPR1+ taMPs are a novel biomarker of HCC and CCA liquid biopsy that permit a non-invasive assessment of the presence and possible extent of these cancers in patients with advanced liver diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
科科科科发布了新的文献求助10
2秒前
3秒前
忧虑的四娘完成签到,获得积分10
4秒前
幽默的访冬完成签到,获得积分10
6秒前
故顾发布了新的文献求助10
8秒前
13秒前
xlb发布了新的文献求助10
19秒前
失眠晟睿完成签到,获得积分10
21秒前
u257616完成签到,获得积分10
26秒前
u274354完成签到,获得积分10
28秒前
yueyueyeu完成签到,获得积分10
49秒前
吃菜菜完成签到 ,获得积分10
50秒前
求论文通过关注了科研通微信公众号
56秒前
58秒前
黑球发布了新的文献求助10
1分钟前
炙热的万怨完成签到,获得积分10
1分钟前
bkagyin的应助被专注凌柏采纳,获得10
1分钟前
jianrun完成签到 ,获得积分10
1分钟前
科科科科完成签到,获得积分10
1分钟前
灵巧雨寒完成签到,获得积分10
1分钟前
1分钟前
1分钟前
愉快飞薇完成签到,获得积分10
1分钟前
小马甲的应助被怡然白玉采纳,获得10
1分钟前
美好如凡发布了新的文献求助10
1分钟前
KKUMee完成签到,获得积分10
1分钟前
1分钟前
Vicky发布了新的文献求助10
1分钟前
美好如凡完成签到,获得积分10
1分钟前
1分钟前
橙子发布了新的文献求助10
1分钟前
专注凌柏发布了新的文献求助10
1分钟前
NI完成签到 ,获得积分10
1分钟前
思源的应助被科科科科采纳,获得10
1分钟前
义气亦竹完成签到,获得积分10
1分钟前
汉堡包的应助被美好如凡采纳,获得10
1分钟前
帅气寄风完成签到,获得积分10
1分钟前
英俊的铭的应助被Vicky采纳,获得10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185108
求助须知:如何正确求助?哪些是违规求助? 9574040
关于积分的说明 21834008
捐赠科研通 7782564
什么是DOI,文献DOI怎么找? 3434500
关于科研通互助平台的介绍 2558743
邀请新用户注册赠送积分活动 2481201